Please assess the completion status of the following clinical trial:

Trial Title: Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female person aged 40 or older~* Subject with diagnosed lower limb ischemia (Fontaine-Pokrovsky Stages IIa-III of chronic limb ischemia)~* Signed informed consent~Exclusion Criteria:~* Any disease that can, in the opinion of the treating physician, affect the outcome of the study~* Patients with addictive disorders or substance abuse~* Pregnancy or nursing~* All other exclusion criteria listed in the summary of product characteristics (SmPC)

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Neovasculgen® (Type: EXPERIMENTAL): Single group prospective treatment
- standard care (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).